Coroflex stent study for selected small heart artery blockages
Part of Heart & circulation clinical trials.
This trial studies a new heart stent (called Coroflex ISAR NEO) for people who need a procedure to open a narrowed coronary artery. It may help improve long-term results for patients with certain small, short blockages who can safely take the required blood-thinning medicines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You must be 18 years or older
- Your doctor has decided you need a heart “angioplasty/stent” procedure (PCI) for your usual treatment plan
- Your blockage is a “new” lesion about 2 to 4 mm long
- You must be willing to sign informed consent to join the study
- You must be able to take the needed blood-thinning (anti-platelet and/or anti-coagulation) medicines safely
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This trial tests a new type of heart stent in people who also take daily blood thinners. The stent is very thin and releases medicine over time to help keep the artery open, and the coating eventually dissolves. It may be a safer option for people on blood thinners who need a stent.
This study looks at how safe and effective a specific stent (SUPRAFLEX CRUZ) is when used in real-world care for people with heart artery blockages in more than one artery. Some participants will also be selected if their heart pumping strength is reduced.
This trial tests a special balloon coated with medicine to treat blocked small arteries in the heart. It may help people who have new blockages and are getting a procedure to open those arteries.
This study tests a coronary stent approach for people with significantly blocked heart arteries. It may help by improving blood flow, and it compares treatment in a structured way while monitoring safety and outcomes.
This study monitors patients who receive a Coroflex ISAR NEO stent to track how well it works over time. It helps doctors understand the safety and effectiveness of this specific stent.
This trial tests a new drug-coated balloon (Genoss SCB) versus an existing one (SeQuent Please NEO) for people whose heart stents have re-narrowed. It aims to see which balloon better keeps the artery open.
Hear when a new Ischemic Heart Disease trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.